The spectrum of polymyalgia rheumatica in Northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study

Journal of Rheumatology

Volumn 26, Issue 6, 1999, Pages 1326-1332

  González Gay, Miguel A ^a   García Porrúa, Carlos ^b   Vázquez Caruncho, Manuel ^b   Dababneh, Adele ^b   Hajeer, Ali ^b   Ollier, William E R ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b NONE

Author keywords

HLA DRB1*04; Incidence; Polymyalgia rheumatica; Relapses

Indexed keywords

HLA DR ANTIGEN; PREDNISONE;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GIANT CELL ARTERITIS; HLA TYPING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; RELAPSE; RHEUMATIC POLYMYALGIA; SPAIN; STEROID THERAPY;

AGE FACTORS; AGED; AGED, 80 AND OVER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HLA-DR ANTIGENS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PREDNISONE; RECURRENCE; SEX FACTORS; SPAIN; TEMPORAL ARTERITIS;

EID: 0345643321     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10 year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
2. Spiera H, Davison S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med 1978;45:225-9.
3. Healey LA. The spectrum of polymyalgia rheumatica. Clin Geriatr Med 1988;4:323-31.
4. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County. Minnesota, 1970-1991. Arthritis Rheum 1995;38:369-73.
5. Bengtsson BA, Malmvall B-E. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum 1981;24:899-904.
6. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish County: a prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-9.
7. Noltorp S, Svensson B. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community. Clin Exp Rheumatol 1991;9:351-5.
8. Schaufelberger C, Bengtsson B-A, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995;34:261-4.
9. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-9.
10. Salvarani C, Macchioni P, Tartoni PL, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15.
11. Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum 1991;34:351-6.
12. González-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171-6.
13. González-Gay MA, Blanco R, Sánchez-Andrade A, Vázquez-Caruncho M. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features. J Rheumatol 1997;24:2166-70.
14. Cohen MD, Ginsburg WW. Polymyalgia rheumatica. Rheum Dis Clin North Am 1990;16:325-39.
15. Salvarani C, Cantini F, Macchioni PL, et al. Distal musculoskeletal manifestations in polymyalgia rheumatica. Arthritis Rheum 1998;41:1221-6.
16. Healey LA. What's in a name? [commentary]. J Rheumatol 1998;25:5.
17. Bahlas S, Ramos-Remus C, Davis P. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1998;25:99-104.
18. Healey LA. Polymyalgia rheumatica and seronegative rheumatoid arthritis may be the same entity. J Rheumatol 1992;19:270-2.
19. González-Gay MA, Alonso MD, Agüero JJ, Bal M, Fernández-Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol 1992;19:277-80.
20. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
21. Lie JT and the Members and Consultants of the American College of Rheumatology Subcommittee on classification of vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
22. Hamilton CR Jr, Shelley WN, Tumulty PA. Giant-cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine (Baltimore) 1971;50:1-27.
23. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis. A 25 year epidemiological, clinical and pathologic study. Ann Intern Med 1978;88:162-7.
24. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
25. González-Gay MA, García-Porrúa C, Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998;25:1750-5.
26. Dababneh A, González-Gay MA, García-Porrúa C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998;25:2140-5.
27. Dababneh A, Farhan A, Payton A, Hajeer AH, Thomson W, Ollier WER. A comparative study of HLA-DR4 subtyping by SSCP versus sequencing-based typing and INNO-Lipa strips [abstract]. Eur J Immunogenetics 1997;24:70.
28. General Secretary of Public Health. Technical information on public health. Series B. Number 6. Secretary of Health and Social Services. Santiago de Compostela, Spain; 1995.
29. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons; 1981:168-73.
30. Armitage P, Berry G. Further analysis of categorical data. In: Armitage P, Berry G, editors. Statistical methods in medical sciences. Oxford: Blackwell; 1994:436-43.
31. Franzén P, Sutinen S, Von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland. An epidemiologic and pathology study, 1984-1988. J Rheumatol 1992;19:273-80.
32. Guerne P-A, Salvi M, Seitz M, et al. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. J Rheumatol 1997;24:671-6.